|
|
|
|
DiovanPharmaceutical Business Review ...the lucrative statin market. NKS104 was also seen as a possible follow-on product to Novartis' Diovan (valsartan). The company is ... Novartis $266m charge on axed drug Dec 16, 2005 CNN International ..."Novartis had already stopped the development of this statin to be used in combination with Diovan (Novartis' top selling hypertension drug) in the third ... Health: A silent killer Dec 24, 2005 Malay Mail, The Health Ministry has approved Diovan to improve the survival rate after a heart attack. This approval makes Diovan the only ARB ... Novartis Abandons Development of Cholesterol Drug (Update4) Dec 16, 2005 Bloomberg ...of $66 million in the third quarter related to pitavastatin and said it was no longer developing it for use with heart medication Diovan, the company's best ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |